Profound Medical Corp. has announced that it will participate in the Stifel 2026 Healthcare Conference, scheduled for November 12, 2026. This event is significant as it highlights the company's advancements in interventional MRI technology, particularly in prostate care.
The conference will feature presentations from key executives, including President Richard Fabian and Chief Executive Officer Arun Menawat. They will discuss the company's innovative products, including the TULSA-PRO platform, which offers incision-free prostate ablation.
Profound Medical Corp., traded on Nasdaq under the ticker symbol PROF, is a commercial-stage medical device company specializing in surgical and medical instruments and apparatus (SIC: 3841). The company focuses on developing and marketing interventional MRI procedures that enhance patient care.
According to the recent SEC filing, "On November 9, 2026, Profound Medical Corp. issued a press release announcing that the Company’s management will participate in the Stifel 2026 Healthcare Conference on Thursday, November 12, 2026 in New York City." This participation is expected to increase the visibility of Profound's innovative solutions in the medical field.
The company's technologies, such as TULSA-PRO and Sonalleve, are designed to provide personalized treatment options while minimizing the risks associated with traditional surgical methods. With FDA clearance and approvals in various global markets, Profound is positioned to lead advancements in MRI-guided therapies.
As the healthcare industry continues to evolve, Profound Medical's participation in this conference may influence investor interest and competitive dynamics within the surgical and medical instruments sector. The filing does not indicate any further actions following the conference.
Read Next
Q/C Technologies Enters Omnibus Amendment Agreement
ONE Nuclear Energy settles consulting fees with stock issuance
HCW Biologics delays stockholder vote amid quorum issues
bioAffinity Technologies amends share structure in 8-K filing
VisionWave amends sponsorship deal with Hen Basketball Haifa Club
Apimeds Pharmaceuticals Amends Agreement with FreeT Inc.










